Fewer cardiovascular drugs being studied in clinical trials

The number of cardiovascular drugs in the research pipeline has declined across all phases of development in the last 20 years even as cardiovascular disease has become the number one cause of death world-wide, according ...

Diseases, Conditions, Syndromes

Discovery of new Hepatitis C virus mechanism

Researchers at Osaka University, Japan uncovered the mechanisms that suppress the propagation of the hepatitis C virus (HCV) with the potential of improving pathological liver conditions. Using model mice, they confirmed ...

page 8 from 23